Body Size and the Risk of Primary Hyperparathyroidism in Women: A Cohort Study

被引:9
|
作者
Vaidya, Anand [1 ,4 ]
Curhan, Gary C. [2 ,3 ,4 ,5 ]
Paik, Julie M. [2 ,3 ,4 ,5 ]
Wang, Molin [5 ]
Taylor, Eric N. [3 ,6 ]
机构
[1] Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, 75 Francis St, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Div Renal Med, 75 Francis St, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA
[4] Harvard Med Sch, Boston, MA USA
[5] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA
[6] Maine Med Ctr, Div Nephrol & Transplantat, Portland, ME 04102 USA
基金
美国国家卫生研究院;
关键词
PRIMARY HYPERPARATHYROIDISM; PARATHYROID HORMONE; WEIGHT; WAIST CIRCUMFERENCE; BODY MASS INDEX; PARATHYROID-HORMONE LEVELS; BONE-MINERAL DENSITY; PHYSICAL-ACTIVITY; MASS INDEX; VITAMIN-D; REPRODUCIBILITY; VALIDITY; WEIGHT; ASSOCIATION; CALCIUM;
D O I
10.1002/jbmr.3168
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Greater body weight and fat mass have been associated with higher serum parathyroid hormone levels and a higher prevalence of primary hyperparathyroidism (P-HPTH) in women. However, prospective studies to evaluate whether greater body size associates with a higher incidence of developing P-HPTH have not been reported. We investigated whether greater body size was independently associated with a higher risk for developing P-HPTH in women. We conducted a prospective cohort study of 85,013 female participants in the Nurses' Health Study I followed for up to 26 years. Body size was measured via multiple metrics: weight, body mass index (BMI), and waist circumference (WC). Weight and BMI were assessed every 2 years from 1986 to 2012, and WC was assessed in 1986, 1996, and 2000. Detailed dietary and demographic exposures were quantified via validated biennial questionnaires. Incident cases of P-HPTH were confirmed by individual medical record review. Cox proportional hazards models were used to evaluate whether WC, weight, and BMI were independent risk factors for developing P-HPTH. Models were adjusted for demographic variables, comorbidities, medications, intakes of calcium and vitamin D, and exposure to ultraviolet light. We confirmed 491 incident cases of P-HPTH during 2,128,068 person-years of follow-up. The multivariable-adjusted relative risks for incident P-HPTH increased across quartiles of WC: Q1, ref; Q2, 1.34 (0.97, 1.86); Q3, 1.70 (1.24, 2.31); Q4, 2.27 (1.63, 3.18); p trend < 0.001. Similarly, the multivariable-adjusted risks for incident P-HPTH increased across quartiles of weight: Q1, ref; Q2, 1.23 (0.92, 1.65); Q3, 1.63 (1.24, 2.14); Q4, 1.65 (1.24, 2.19); p trend < 0.001. A similar but statistically non-significant trend was observed across quartiles of BMI (p trend = 0.07). In summary, body size may be an independent and modifiable risk factor for developing P-HPTH in women. (C) 2017 American Society for Bone and Mineral Research.
引用
收藏
页码:1900 / 1906
页数:7
相关论文
共 50 条
  • [1] Calcium intake and risk of primary hyperparathyroidism in women: prospective cohort study
    Paik, Julie M.
    Curhan, Gary C.
    Taylor, Eric N.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2012, 345
  • [2] Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism
    Vestergaard, P
    Mollerup, CL
    Frokjær, VB
    Christiansen, P
    Blichert-Toft, M
    Mosekilde, L
    [J]. BRITISH MEDICAL JOURNAL, 2000, 321 (7261): : 598 - 602
  • [3] The risk of fractures in postmenopausal women with primary hyperparathyroidism
    De Geronimo, Simona
    Romagnoli, Elisabetta
    Diacinti, Daniele
    D'Erasmo, Emilio
    Minisola, Salvatore
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2006, 155 (03) : 415 - 420
  • [4] EXPERIENCE WITH CINACALCET IN PRIMARY HYPERPARATHYROIDISM: RESULTS FROM THE SWISS PRIMARY HYPERPARATHYROIDISM COHORT STUDY
    Trombetti, Andrea
    Rizzoli, Rene
    Meier, Christian
    Henzen, Christoph
    Torriani, Catherine
    Rohrer, Andreas
    Herrmann, Francois
    Braendle, Michael
    Christ, Emanuel
    Kraenzlin, Marius
    [J]. OSTEOPOROSIS INTERNATIONAL, 2011, 22 : 235 - 236
  • [5] INCREASED RISK OF MALIGNANT DISEASES AFTER SURGERY FOR PRIMARY HYPERPARATHYROIDISM - A NATIONWIDE COHORT STUDY
    PALMER, M
    ADAMI, HO
    KRUSEMO, UB
    LJUNGHALL, S
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1988, 127 (05) : 1031 - 1040
  • [6] Body size and the risk of endometrial cancer by hormone therapy use in postmenopausal women in the California Teachers Study cohort
    Canchola, Alison J.
    Chang, Ellen T.
    Bernstein, Leslie
    Largent, Joan A.
    Reynolds, Peggy
    Deapen, Dennis
    Ursin, Giske
    Horn-Ross, Pamela L.
    [J]. CANCER CAUSES & CONTROL, 2010, 21 (09) : 1407 - 1416
  • [7] Body size and the risk of endometrial cancer by hormone therapy use in postmenopausal women in the California Teachers Study cohort
    Alison J. Canchola
    Ellen T. Chang
    Leslie Bernstein
    Joan A. Largent
    Peggy Reynolds
    Dennis Deapen
    Giske Ursin
    Pamela L. Horn-Ross
    [J]. Cancer Causes & Control, 2010, 21 : 1407 - 1416
  • [8] 131I treatment for thyroid cancer and risk of developing primary hyperparathyroidism: a cohort study
    Lin, Chien-Mu
    Doyle, Pat
    Tsan, Yu-Tse
    Lee, Chang-Hsing
    Wang, Jung-Der
    Chen, Pau-Chung
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (02) : 253 - 259
  • [9] 131I treatment for thyroid cancer and risk of developing primary hyperparathyroidism: a cohort study
    Chien-Mu Lin
    Pat Doyle
    Yu-Tse Tsan
    Chang-Hsing Lee
    Jung-Der Wang
    Pau-Chung Chen
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 : 253 - 259
  • [10] VITAMIN D AND THE RISK OF VFX IN POSTMENOPAUSAL WOMEN WITH PRIMARY HYPERPARATHYROIDISM
    Brutskaya-Stempkovskaya, E. V.
    Shepelkevich, A. P.
    Vasilieva, N. A.
    Dydyshka, Y. V.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S367 - S367